Depression isn’t one condition. For most people, it responds reasonably well to antidepressant medications and therapy — with time, patience, and the right clinical guidance. But for a significant number of patients, two or more treatments fail to deliver meaningful improvement. That’s what psychiatrists call treatment-resistant depression, or TRD.
If you’ve been managing depression for years and standard approaches haven’t worked, that’s not a failure on your part. It often reflects a biological reality — that your brain’s chemistry or neural circuitry doesn’t respond to conventional pathways in the usual way.
Two advanced psychiatric treatments are changing the picture for patients in this situation: esketamine therapy (Spravato) and Transcranial Magnetic Stimulation (TMS). Both are now available at Newcastle Vitality Clinic (NVC Medical) in Jumeirah, under the supervision of consultant psychiatrist Dr. Hamid Alhaj.
What Is Treatment-Resistant Depression?
Treatment-resistant depression is typically defined as depression that hasn’t responded adequately to at least two different antidepressant treatments taken at the correct dose for sufficient time. It’s more common than people realize — research suggests roughly 30% of people with major depressive disorder fall into this category.
TRD isn’t just about sadness that doesn’t lift. It often involves:
- Persistent fatigue and loss of motivation that standard medications haven’t touched
- Cognitive symptoms — poor concentration, brain fog, difficulty making decisions
- Physical symptoms including sleep disruption, appetite changes, and pain
- Anhedonia- loss of pleasure and interest making life look gloomy and not enjoyable
- A cycle of trying medications, experiencing side effects, and seeing minimal benefit
For patients in this position, the arrival of esketamine and TMS represents a genuine clinical shift — not just another medication to try.
Esketamine Therapy (Spravato) in Dubai: How It Works
Esketamine — sold under the brand name Spravato as a nasal spray — is a derivative of ketamine that works through a completely different mechanism than conventional antidepressants.
Most antidepressants target the serotonin or norepinephrine systems. Esketamine acts on glutamate receptors — specifically NMDA receptors — which play a central role in mood regulation, brain plasticity, and the formation of neural connections. By acting on this pathway, esketamine can rapidly restore disrupted mood circuits in a way that traditional antidepressants can’t.
One of the most clinically significant aspects of esketamine is its speed. Traditional antidepressants typically take 4–6 weeks to show effect. Esketamine can produce meaningful improvement within hours to days — which is particularly important for patients experiencing severe depressive episodes.
Esketamine therapy for TRD has received FDA approval and is now administered in DHA-licensed psychiatric settings across the UAE. At NVC Medical, sessions are conducted in a supervised clinical environment. Patients receive the nasal spray under observation and remain at the clinic for approximately two hours post-administration.
TMS (Transcranial Magnetic Stimulation) in Dubai: A Drug-Free Alternative
Transcranial Magnetic Stimulation is a non-invasive, drug-free psychiatric treatment that uses precisely targeted magnetic pulses to stimulate specific areas of the brain associated with mood regulation — primarily the left dorsolateral prefrontal cortex.
When this brain region is underactive, as it commonly is in depression, TMS therapy helps reactivate it — stimulating neurons, improving connectivity, and gradually restoring more normal mood circuit function.
What to Expect from TMS Treatment
TMS sessions at NVC Medical in Jumeirah typically run 20–40 minutes. Patients sit comfortably while the device delivers magnetic pulses. There’s no anesthesia, no sedation, no recovery time — most patients return to normal activities immediately after.
A standard TMS course involves daily sessions over 4–6 weeks. Many patients notice gradual mood improvements from around week 2 or 3, with the full benefit typically consolidating by the end of the course.
TMS vs. Medication: Key Differences
- TMS acts directly on brain circuits, not through systemic chemical pathways
- No medication-related side effects such as weight gain, sexual dysfunction, or emotional blunting
- Suitable for patients who can’t tolerate antidepressant side effects
- Can be used alongside existing medications or as a standalone treatment
- FDA-cleared for major depressive disorder
Esketamine vs. TMS: Which Is Right for You?
This is a clinical decision that should be made with a psychiatrist — not based on what’s trending online. Both treatments have strong evidence bases for TRD, but they suit different patient profiles.
Esketamine therapy tends to be considered when rapid response is a priority — for severe depressive episodes, high distress levels, or where speed of improvement is clinically important. TMS is often preferred as a first advanced option given its non-invasive nature, low side-effect profile, and strong long-term efficacy data.
At NVC Medical, Dr. Hamid Alhaj conducts a full psychiatric assessment before recommending either pathway. The goal is a treatment decision based on your specific history, symptoms, and biology — not a one-size-fits-all protocol.
What About Regular Depression — Is NVC Medical Only for TRD?
Not at all. The psychiatry team at NVC Medical provides comprehensive mental health care — from anxiety and mood disorders to ADHD and emotional eating. Advanced treatments like esketamine and TMS are available for appropriate cases, but most patients are managed through evidence-based psychiatric care that starts with careful assessment and a clinically reasoned treatment plan.
Frequently Asked Questions
Is esketamine (Spravato) available in Dubai?
Yes. Esketamine nasal spray is administered in approved clinical settings by DHA-licensed psychiatrists. NVC Medical in Jumeirah offers supervised esketamine therapy for qualifying patients with treatment-resistant depression.
How many TMS sessions are typically needed?
A standard course is usually 20–30 sessions delivered over 4–6 weeks. Your psychiatrist will assess response and may recommend a maintenance schedule after the initial course.
Is TMS covered by health insurance in the UAE?
Coverage varies by insurer. Some plans now cover TMS therapy for treatment-resistant depression with appropriate psychiatric documentation. NVC Medical can provide the clinical records needed to support insurance applications.
Can I continue taking my antidepressants during esketamine or TMS treatment?
In most cases, yes. Esketamine is prescribed as an adjunctive treatment alongside existing antidepressant medication. TMS can also be used in conjunction with medications. Your psychiatrist will review your current regimen before treatment begins.
Key Takeaways
- Treatment-resistant depression (TRD) affects a significant proportion of people with major depressive disorder — it’s a recognized clinical condition, not a personal failure
- Esketamine (Spravato) works via glutamate pathways, offering rapid improvement for patients who haven’t responded to traditional antidepressants
- TMS is a drug-free, non-invasive option using targeted magnetic stimulation to restore mood circuit function — FDA-cleared and well-evidenced
- Both treatments are available at NVC Medical in Jumeirah under the supervision of consultant psychiatrist Dr. Hamid Alhaj
- The right treatment is chosen through comprehensive psychiatric assessment — not generic protocol
If standard treatment hasn’t worked for your depression, a proper psychiatric assessment may reveal options you haven’t tried yet. NVC Medical’s psychiatry team at 109 Century Plaza, Jumeirah Beach Road, Dubai offers advanced psychiatric care including esketamine therapy and TMS. Book a consultation at nvc-medical.ae.